Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia 4Myelodysplastic Syndromes 2Leukemia, Myeloid, Acute 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neoplasms, Plasma Cell 1Multiple Myeloma 1Lymphoma 1Leukemia, Myeloid, Accelerated Phase 1Hodgkin Disease 1Blast Crisis 1

Interventions

Peripheral Blood Stem Cell Transplantation 14Mycophenolic Acid 9Cyclosporine 9fludarabine phosphate 8Tacrolimus 7Methotrexate 6Cyclophosphamide 5Busulfan 5Whole-Body Irradiation 4Radiotherapy 4Filgrastim 4Melphalan 3Imatinib Mesylate 3nilotinib 2aldesleukin 2Thiotepa 2Stem Cell Transplantation 2Flow Cytometry 2Decitabine 2Cord Blood Stem Cell Transplantation 2Blood Specimen Collection 2Antilymphocyte Serum 2Alemtuzumab 2sargramostim 1ruxolitinib 1ponatinib 1montanide ISA 51 1liposomal doxorubicin 1fludarabine 1ethanolamine oleate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Leukemia, Myeloid, Accelerated Phase × Methylprednisolone Acetate × Clear all
NCT00002831 2018-10-26

Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous or Acute Leukemia

M.D. Anderson Cancer Center

Phase 1/2 Completed
24 enrolled
Other hematologic neoplasm

Blast Crisis, Leukemia, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡